EACVI Premium Access

Left atrial shape as a marker of atrial myopathy in embolic stroke of undetermined source

logo

Date: 15 March 2024
Journal: European Heart Journal - Cardiovascular Imaging , Volume 25 , Issue 8 , Pages 1155 - 1163
Topic: DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE, Stroke, IMAGING, Echocardiography
Authors: A. Ferkh , K. De Silva , J. Pham , L. Stefani , K. Byth , A. Clark , S. Trivedi , S. Nagaratnam , A. Duggins , E. Kizana , A. Thiagalingam , L. Thomas

ESC Journals

AbstractAims

Embolic stroke of undetermined source (ESUS) results in significant morbidity. A left atrial (LA) myopathy is implicated in a proportion of these patients. We hypothesized that LA shape varies by cause of stroke [CE (cardioembolic) vs. ESUS].

Methods and results

A total of 236 ischaemic stroke and atrial fibrillation (AF) patients and controls were recruited prospectively. AF was classified as paroxysmal AF (PAF) or persistent AF (PersAF). Stroke patients comprised CE stroke secondary to AF and ESUS. There were 81 AF (47 PAF, 34 PersAF), 50 ESUS, 57 CE patients [subdivided into CE with PAF (CEpaf) and CE with PersAF (CEpers)], and 48 controls. Echocardiographic parameters including LA volume, function, and shape/sphericity (3D LA sphericity and 2D-derived LA circularity, ellipticity, sphericity, and eccentricity indices) were evaluated. Increased LA volume and sphericity with LA dysfunction were present in CE, AF, and ESUS groups compared with controls. K-means cluster analysis demonstrated a spectrum of LA myopathy with controls at the lowest and CEpers and PersAF at the upper extremes, with ESUS, PAF, and CEpaf being similar and falling between these extremes. After adjusting for age, sex, and left ventricular (LV) and LA parameters, LA sphericity markers differentiated ESUS from controls (P < 0.01).

Conclusion

Alterations in LA shape are present in ESUS, AF, and CE patients, particularly increased spherical remodelling. The novel markers of LA sphericity proposed may identify LA myopathy in ESUS patients and potentially guide management for secondary prevention.

About the contributors

Aaisha Ferkh

Role: Author

Kasun De Silva

Role: Author

Jennifer Pham

Role: Author